78
Views
23
CrossRef citations to date
0
Altmetric
Original

Primary breast lymphoma: Long-term treatment outcomeand prognosis

, , , &
Pages 2102-2109 | Received 30 Dec 2005, Accepted 03 Mar 2006, Published online: 01 Jul 2009

References

  • Wiseman C, Liao K T. Primary lymphoma of the breast. Cancer 1972; 29: 1705–1712
  • Park Y H, Kim S H, Choi S J, Ryoo B Y, Kang Y K, Lee S S. Primary malignant lymphoma of the breast: clinicopathological study of nine cases. Leuk Lymphoma 2004; 45: 327–330
  • Ha C S, Dubey P, Goyal L K, Hess M, Cabanillas F, Cox J D. Localized primary non-Hodgkin lymphoma of the breast. Am J Clin Oncol 1998; 21: 376–380
  • Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin's lymphomas of the breast. Cancer 1992; 69: 725–735
  • Domchek S M, Hecht J L, Fleming M D, Pinkus G S, Canellos G P. Lymphomas of the breast. Primary and secondary involvement. Cancer 2002; 94: 6–13
  • Liu F F, Clark R M. Primary lymphoma of the breast. Clin Radiol 1986; 37: 567–570
  • The International non-Hodgkin's Lymphoma Prognostic Factors Project: a predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–994
  • Rathmell A J, Gospodarowicz M K, Sutcliffe S B, Clark R M. Localized extradural lymphoma: survival, relapse pattern and functional outcome. The Princess Margaret Hospital Lymphoma Group. Radiother Oncol 1992; 24: 14–20
  • Ribrag V, Bibeau F, El Weshi A, Frayfer J, Fadel C, Cebotaru C, Laribi K, Fenaux P. Primary breast lymphoma: a report of 20 cases. Br J Haematol 2001; 115: 253–256
  • Wong W W, Schild S E, Halyard M Y, Schomberg P J. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience. J Surg Oncol 2002; 80: 19–25
  • Huang D Z, He X H, Yang S, Shi Y K. Clinical and pathological analysis of 15 cases with primary breast lymphoma. Ai Zheng 2004; 23: 939–942
  • Au W Y, Chan A C, Chow L W, Liang R. Lymphoma of the breast in Hong Kong Chinese. Hematol Oncol 1997; 15: 33–38
  • Dhabhar B N, Saikia T K, Soman C S, Advani S H. Primary lymphoma of breast-report of six cases and review of literature. Indian J Cancer 1992; 29: 164–168
  • Marwah N, Gupta S, Mathur S K, Singh S, Marwah S, Arora B. Primary malignant lymphoma of the breast. Indian J Pathol Microbiol 2003; 46: 65–66
  • Jeon H J, Akagi T, Hoshida Y, Hayashi K, Yoshino T, Tanaka T, et al. Primary non-Hodgkin malignant lymphoma of the breast. An immunohistochemical study of seven patients and literature review of 152 patients with breast lymphoma in Japan. Cancer 1992; 70: 2451–2459
  • Brogi E, Harris N L. Lymphoma of the breast: pathology and clinical behavior. Semin Oncol 1999; 26: 357–364
  • Mattia A R, Ferry J A, Harris N L. Breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol 1993; 17: 574–587
  • Hugh J C, Jackson F I, Hanson J, Poppema S. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer 1990; 66: 2602–2611
  • Gholam D, Bibeau A, El Weshi A, Bosq J, Ribrag V. Primary breast lymphoma. Leuk Lymphoma 2003; 44: 1173–1178
  • Lyons J A, Myles J, Pohlman B, Macklis R M, Crowe J, Crownover R L. Treatment of prognosis of primary breast lymphoma: a review of 13 cases. Am J Clin Oncol 2000; 23: 334–336
  • DeBlasio D, McCormick B, Straus D, Smith M, Brustein S, Nisce L, Fuks Z. Definitive irradiation for localized non-Hodgkin's lymphoma of breast. Int J Radiat Oncol Biol Phys 1989; 17: 843–846
  • Smith M R, Brustein S, Straus D. Localized non-Hodgkin's lymphoma of the breast. Cancer 1987; 59: 351–354
  • Chen M G, Prosnitz L R, Gonzalez-Serva A, Fischer D B. Results of radiotherapy in control stage I and II non-Hodgkin's lymphoma. Cancer 1979; 43: 1245–1254
  • Monfardini S, Banfi A, Bonadonna G, Rilke F, Milani F, Valagussa P, et al. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1980; 6: 125–134
  • Miller T P, Dahlberg S, Cassady J R. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998; 2: 21–26
  • Aviles A, Delgado S, Nambo M J, Neri N, Murillo E, Cleto S. Primary breast lymphoma: results of a controlled clinical trial. Oncology 2005; 69: 256–260
  • Liu M T, Hsieh C Y, Wang A Y, Pi C P, Chang T H, Huang C C, et al. Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 cases. Ann Saudi Med 2005; 25: 288–293
  • Gordon L I, Harrington D, Andersen J, Colgan J, Glick J, Neiman R, et al. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 1992; 327: 1342–1349
  • Fisher R I, Gaynor E R, Dahlberg S, Oken M M, Grogan T M, Mize E M, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–1006
  • Tilly H, Mounier N, Lederlin P, Briere J, Dupriez B, Sebban C, et al. Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: The LNH 87-1 study. J Clin Oncol 2000; 18: 1309–1315
  • Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P, et al. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH-87 protocol. A Group d'Etude des Lymphomes de l'Adulte study. J Clin Oncol 2000; 18: 3025–3030
  • Fisher R I, Gaynor E R, Dahlberg S, Oken M M, Grogan T M, Mize E M, et al. A phase III comparison of CHOP versus m-BACOD versus ProMACE-CytaBOM versus MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study. Ann Oncol 1994; 5(Suppl 2)91–95
  • Abbondanzo S L, Seidman J D, Lefkowitz M, Tavassoli F A, Krishnan J. Primary diffuse large B-cell lymphoma of the breast: a clinicopathologic study of 31 cases. Pathol Res Pract 1996; 192: 37–43
  • Pinheiro R F, Colleoni G W, Baiocchi O C, Kerbauy F R, Duarte L C, Bordin J O. Primary breast lymphoma: an uncommon but curable disease. Leuk Lymphoma 2003; 44: 149–151
  • Imai T, Shiga T. Primary non-Hodgkin's malignant lymphoma of the breast: long-term follow-up. Breast 2004; 13: 152–154
  • Barista I, Baltali E, Tekulman G, Kars A, Ruacan S, Ozisik Y, et al. Primary breast lymphomas – a retrospective analysis of 12 cases. Acta Oncol 2000; 39: 135–139
  • Krol A D, Hermans J, Dawson L, Snijder S, Wijermans P W, Kluin-Nelemans H C, et al. Treatment patterns of failure, and survival of patients with stage I nodal and extranodal non-Hodgkin's lymphomas, according to data in the population-based registry of the Comprehensive Cancer Centre West. Cancer 1998; 83: 1612–1619
  • Lopez-Guillermo A, Colomo L, Jimenez M, Bosch F, Villamor N, Arenillas L, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005; 23: 2797–2804
  • Salvagno L, Soraru M, Busetto M, Puccetti C, Sava C, Endrizzi L, et al. Gastric non-Hodgkin's lymphoma: analysis of 252 patients from a multicenter study. Tumori 1999; 85: 113–121
  • Li Y X, Coucke P A, Li J Y, Gu D Z, Liu X F, Zhou L Q, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 1998; 83: 449–456

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.